Ibu Ratiopharm

Ibuprofen, the active ingredient in Ibu Ratiopharm, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for systemic use. It provides analgesic, antipyretic and anti‑inflammatory effects, making it suitable for the relief of mild to moderate pain, fever reduction, and inflammation associated with musculoskeletal and other conditions.

GNH USA supplies Ibu Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across global markets through robust quality systems and timely delivery.

Ibu Ratiopharm, an ibuprofen product, acts on inflammatory pathways to relieve several common conditions. - Pain: Provides relief from mild to moderate acute pain such as headache, dental pain, or musculoskeletal discomfort. - Fever: Reduces elevated body temperature associated with infections or inflammatory states. - Inflammation: Decreases swelling and inflammation in conditions like arthritis or soft‑tissue injuries. - Post‑operative discomfort: Helps manage pain and inflammation after minor surgical procedures.

Ibu Ratiopharm may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache: mild to moderate headache may occur. - Dizziness: transient feeling of light‑headedness. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration: potentially life‑threatening hemorrhage. - Renal impairment: reduced kidney function or acute renal failure. - Severe allergic reaction: anaphylaxis, angioedema, or bronchospasm. - Hepatotoxicity: elevated liver enzymes or hepatitis.

Before prescribing Ibu Ratiopharm, clinicians should consider several safety factors to minimise risk. - Assess gastrointestinal risk: evaluate history of ulcer or bleeding before use. - Monitor renal function: avoid in patients with severe kidney disease or dehydration. - Use lowest effective dose: limit duration to the shortest period necessary. - Avoid in third trimester pregnancy: risk of fetal complications. - Review concomitant anticoagulants: increased bleeding risk with warfarin or similar agents. - Store at room temperature: keep below 25 °C in the original packaging, protected from moisture.

Ibu Ratiopharm can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - High‑dose aspirin: additive gastrointestinal toxicity. - ACE inhibitors: may reduce renal perfusion and function. - Diuretics: potential for reduced kidney function and electrolyte imbalance. - Lithium: ibuprofen can raise lithium serum levels.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): modestly increased bleeding risk. - Methotrexate: ibuprofen may raise methotrexate concentrations, enhancing toxicity.